<DOC>
	<DOCNO>NCT00782964</DOCNO>
	<brief_summary>Observational , non-interventional , longitudinal , prospective , multicenter , open label ( No treatment involve ) . 3 assessment carry . The 1st one baseline , 2sd one significant change pharmacological treatment 3rd one second significant change pharmacological treatment . If isn´t significant change therapeutic plan control assessment carry week 10th 24th . A significant treatment change define change SSRI/SNRI , add another SSRI/SNRI augmentation treatment add SSRI/SNRI . The primary objective describe therapeutical strategy ( antidepressant change , association another antidepressant association another treatment ) management patient MDD incomplete response intolerance antidepressant first second failure ; psychiatrist decide change strategy . Secondary objective include : 1 - To describe clinic profile depressive patient incomplete response intolerance antidepressant first second failure ; 2- To describe profile patient base therapeutic strategy use number therapeutic strategy ; 4- Evaluate use health resource due lack fast onset action , social cost ( productivity , care givers… ) ; 5 - To associate clinical variable therapeutic action psychiatrist .</brief_summary>
	<brief_title>Antidepressant Incomplete Response Depression</brief_title>
	<detailed_description />
	<mesh_term>Depression</mesh_term>
	<mesh_term>Depressive Disorder</mesh_term>
	<mesh_term>Depressive Disorder , Major</mesh_term>
	<mesh_term>Antidepressive Agents</mesh_term>
	<criteria>Provision write inform consent Diagnosed Major Depressive Disorder base DSMIVTR Outpatient change pharmacological therapeutic plan incomplete response intolerance treatment adequate dosage antidepressant ( SSRI/NSRI ) 5 Able understand comply requirement study Mental retardation To recruit clinical trial last 4 week plan inclusion clinical trial followup study MDD secondary substance abuse somatic illness Actual depressive episode &lt; 4 week &gt; 12 month length Current treatment &gt; 1 SSRI/SRNI previous treatment &gt; 1 SSRI/SRNI , augmentation treatment SSRI/SRNI , intravenous antidepressant treatment , TMS , ECT MAO</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>December 2009</verification_date>
	<keyword>Depression</keyword>
	<keyword>Major Depressive Disorder</keyword>
	<keyword>SSRI resistant depression</keyword>
	<keyword>strategy depression</keyword>
</DOC>